Canine Heartworm Disease: Transmission, Prevention, and Treatment

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Canine heartworm disease is a mosquito-borne filarial infection caused by Dirofilaria immitis, with transmission exclusively occurring through the bite of infected mosquitoes; direct dog-to-dog transmission is not possible.
• Diagnosis relies on a combination of antigen ELISA for adult female worm detection, modified Knott's test for microfilariae, and advanced imaging such as thoracic radiography and echocardiography to assess pulmonary artery enlargement and pulmonary hypertension.
• The primary adulticide treatment involves melarsomine dihydrochloride, administered via intramuscular injection, necessitating strict exercise restriction throughout the protocol to mitigate thromboembolic complications.
• Alternative "slow-kill" treatment strategies involve macrocyclic lactones (MLs) in conjunction with doxycycline to target the Wolbachia endosymbiont, though efficacy is generally lower than with melarsomine.
• Prevention is paramount and achieved through monthly administration of macrocyclic lactones (e.g., ivermectin, moxidectin) which target tissue-stage larvae, with year-round prophylaxis recommended in endemic areas.
• The extrinsic incubation period (EIP) for D. immitis larvae within mosquitoes is temperature-dependent, requiring cumulative heartworm development units (HDUs) and consistently above approximately 14°C, influencing geographical distribution and transmission seasonality.

Etiology and Life Cycle

Canine heartworm disease is a mosquito-borne filarial infection caused by the nematode Dirofilaria immitis [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The adult parasites reside within the pulmonary arteries and right ventricle of the heart, causing progressive vascular and parenchymal damage [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. The life cycle involves an obligate intermediate host, mosquitoes of the genera Culex, Aedes, and Anopheles [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Microfilariae (L1 larvae) circulate in the peripheral blood of an infected canid and are ingested by a feeding mosquito [<a href="#ref-1">1</a>]. Within the insect, larvae develop through two molts (L1 to L2, L2 to L3) over a temperature-dependent extrinsic incubation period (EIP) [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. The EIP requires a cumulative thermal input, quantified as heartworm development units (HDUs), and is completed only when ambient temperatures are consistently above a threshold of approximately 14°C [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. This temperature-bounded development restricts the geographical distribution and seasonality of transmission [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Infective L3 larvae are deposited onto the skin during subsequent mosquito blood meals, enter the host through the puncture wound, and molt to L4 and then L5 (immature adult) within the subcutaneous tissues and muscle [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Immature adults migrate to the pulmonary arteries approximately 70 to 90 days post-infection and reach sexual maturity at 6 to 7 months [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>]. Adult worms can survive for 5 to 7 years within the canine host [<a href="#ref-4">4</a>].

How Do You Get Heartworm in Dogs

Transmission occurs exclusively through the bite of a mosquito carrying infective L3 larvae [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The question "how do you get heartworm in dogs" is answered by the vector-borne nature of the parasite: there is no direct dog-to-dog transmission [<a href="#ref-1">1</a>]. The likelihood of infection depends on the density of infected mosquitoes, the duration of exposure, and the absence of chemoprophylaxis [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. In endemic regions, transmission risk is highest during warm months when mosquito activity and EIP completion coincide [<a href="#ref-7">7</a>, <a href="#ref-11">11</a>]. Studies have demonstrated that risk factors for antigen positivity include location in a high-prevalence zone (e.g., northern Queensland, Australia) [<a href="#ref-9">9</a>], adult or geriatric age [<a href="#ref-10">10</a>], male sex [<a href="#ref-10">10</a>], intact reproductive status [<a href="#ref-10">10</a>], and diagnosis during the dry season [<a href="#ref-10">10</a>]. Imported cases, so-called "baggage canine heartworm," can occur when infected mosquitoes are transported in luggage from endemic to non-endemic areas [<a href="#ref-12">12</a>]. Autochthonous infections have been documented in previously non-endemic regions such as Estonia, indicating ongoing northward expansion of D. immitis in Europe [<a href="#ref-13">13</a>].

Epidemiology and Geographic Distribution

Dirofilaria immitis has a cosmopolitan distribution, with endemic foci on every continent except Antarctica [<a href="#ref-7">7</a>, <a href="#ref-14">14</a>]. Prevalence varies widely: a necropsy study of stray dogs in Grenada reported 27.5% positivity [<a href="#ref-15">15</a>], while shelter dogs in Queensland, Australia, showed 9.6% positivity by combined antigen, microfilaria, and PCR testing [<a href="#ref-9">9</a>]. In temperate climates, transmission historically was sporadic, but warming trends have expanded the suitable transmission window [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>, <a href="#ref-13">13</a>]. A survey of European veterinary practitioners indicated that 10% of respondents from non-endemic regions reported an increasing number of cases, and 44% considered it likely that heartworm would become endemic in their area [<a href="#ref-14">14</a>]. In Ukraine, dirofilariasis has transitioned from a sporadic disease to a widespread pathology, attributed to climate change and animal movement [<a href="#ref-5">5</a>]. The development of a public dashboard using HDU-based modeling now allows real-time assessment of transmission risk across Australia [<a href="#ref-8">8</a>].

Pathogenesis and Clinical Signs

The primary pathologic lesions are caused by the presence of adult worms in the pulmonary arteries [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Physical contact between the parasite and the vascular endothelium triggers proliferative endarteritis, villous intimal hyperplasia, and thrombosis [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. The severity of disease is correlated with worm burden, duration of infection, and host immune response [<a href="#ref-3">3</a>]. The bacterial endosymbiont Wolbachia pipientis plays a critical role in driving inflammation; its release upon worm death exacerbates pulmonary thromboembolism and acute respiratory distress [<a href="#ref-2">2</a>, <a href="#ref-18">18</a>]. Chronic infection leads to precapillary pulmonary hypertension (PH) due to irreversible structural remodeling of the arterial wall [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. Clinical signs include cough, exercise intolerance, dyspnea, syncope, and signs of right-sided congestive heart failure (ascites, jugular distension) [<a href="#ref-1">1</a>]. In a cohort of naturally infected dogs, PH (defined by right pulmonary artery distensibility index < 29.5%) was present in 47.4% of cases [<a href="#ref-17">17</a>]. Biomarkers such as cardiac troponin I (cTnI) are elevated in both symptomatic and asymptomatic infections, while N-terminal pro B-type natriuretic peptide (NT-proBNP) is increased only in dogs with clinical signs, reflecting myocardial stretch [<a href="#ref-19">19</a>]. Tumor necrosis factor alpha dynamics have also been investigated as inflammatory markers during diagnosis and treatment [<a href="#ref-20">20</a>].

Diagnostic Approaches

Diagnosis relies on detection of circulating adult female worm antigens, identification of microfilariae, and imaging [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>, <a href="#ref-9">9</a>]. The reference method for antigen detection is a microwell-based enzyme-linked immunosorbent assay (ELISA) targeting glycoproteins shed by adult D. immitis [<a href="#ref-9">9</a>]. Heat treatment of plasma prior to testing can increase optical density in antigen-positive samples, though in one study it did not alter the qualitative result (Cohen's kappa = 0.98) [<a href="#ref-9">9</a>]. Modified Knott's test remains the standard for microfilarial detection and allows morphologic differentiation from Acanthocheilonema reconditum [<a href="#ref-9">9</a>, <a href="#ref-12">12</a>]. Real-time PCR targeting D. immitis DNA provides species confirmation and is particularly useful when antigen tests are positive but microfilariae are absent (occult infections) [<a href="#ref-6">6</a>, <a href="#ref-12">12</a>].

Imaging techniques include thoracic radiography and echocardiography [<a href="#ref-11">11</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-21">21</a>]. Radiographic signs of heartworm disease include enlargement of the caudal lobar pulmonary arteries, increased sternal contact of the cardiac silhouette, reversed-D heart shape, and loss of pulmonary vessel margination [<a href="#ref-11">11</a>, <a href="#ref-21">21</a>]. Objective radiographic measurements such as modified vertebral heart size (VHS) and cardiac sphericity index are feasible and repeatable [<a href="#ref-21">21</a>]. Echocardiography enables direct visualization of adult worms as parallel echogenic lines ("tram tracks") within the pulmonary arteries, evaluation of right ventricular function, and estimation of pulmonary hypertension [<a href="#ref-12">12</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. The pulmonary vein to pulmonary artery ratio (PV:PA ratio) measured by M-mode or two-dimensional echocardiography has high diagnostic accuracy for moderate-to-severe PH (cut-off ≤ 0.845, sensitivity 97%, specificity 94%) [<a href="#ref-16">16</a>]. Tissue Doppler imaging further aids PH assessment, with indices such as E':A' and right myocardial performance index demonstrating excellent sensitivity and specificity [<a href="#ref-17">17</a>].

A summary of diagnostic methods is provided in Table 1.

Table 1. Diagnostic Methods for Canine Heartworm Disease

Treatment Protocols

The adulticide of choice is melarsomine dihydrochloride, an arsenical compound administered via deep intramuscular injection into the paralumbar muscles [<a href="#ref-18">18</a>, <a href="#ref-22">22</a>]. The recommended protocol involves two doses 24 hours apart (2.5 mg/kg each) followed by a third dose 30 days later [<a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Because melarsomine is highly irritative, precise injection technique is critical; ultrasonographic guidance has been proposed to measure muscle depth and monitor drug distribution [<a href="#ref-22">22</a>]. Exercise restriction is mandatory throughout treatment to reduce the risk of thromboembolic complications [<a href="#ref-23">23</a>].

In cases where arsenical therapy is contraindicated or declined, alternative "slow-kill" approaches using macrocyclic lactones (MLs) combined with doxycycline targeting Wolbachia have been employed [<a href="#ref-18">18</a>, <a href="#ref-25">25</a>, <a href="#ref-26">26</a>]. Doxycycline (10 mg/kg twice daily for 28 days) depletes Wolbachia, rendering adult worms more susceptible to MLs and reducing microfilaremia [<a href="#ref-18">18</a>, <a href="#ref-26">26</a>]. Minocycline may be considered as a substitute, with pharmacokinetic-pharmacodynamic analyses suggesting a dose of 3.75 to 5 mg/kg twice daily to achieve anti-Wolbachia efficacy [<a href="#ref-26">26</a>]. The combination of ivermectin or moxidectin with doxycycline has shown adulticidal effects, although efficacy is lower than with melarsomine [<a href="#ref-18">18</a>]. Survey data indicate that 74% of veterinarians surveyed endorsed long-term ML monotherapy (slow-kill) when clients declined melarsomine, despite guideline recommendations against it [<a href="#ref-23">23</a>]. Concerns about ML resistance have emerged, with reports of reduced microfilarial suppression after moxidectin treatment in Australia; however, genotyping of single nucleotide polymorphisms associated with resistance in the USA did not correlate with the observed phenotype [<a href="#ref-27">27</a>].

A treatment decision tree is presented in Figure 1.

graph TD
 A["Confirmed D. immitis infection"] --> B{"Clinical signs?"}
 B -->|"Yes"| C["Evaluate severity of PH and right heart failure"]
 B -->|"No"| D["Asymptomatic"]
 C --> E{"Melarsomine indicated?"}
 E -->|"Yes"| F["Three-dose protocol + exercise restriction + doxycycline 28d"]
 E -->|"No (owner declines / contraindicated)"| G["Slow-kill: monthly ML + doxycycline/minocycline 28d"]
 D --> H{"Melarsomine indicated?"}
 H -->|"Yes"| I["Three-dose protocol + doxycycline"]
 H -->|"No"| J["Slow-kill as above"]
 F --> K["Post-treatment antigen test at 6-12 months"]
 G --> K
 I --> K
 J --> K
 K --> L{"Antigen negative?"}
 L -->|"Yes"| M["Cure confirmed; continue prevention"]
 L -->|"No"| N["Consider retreatment or alternative therapy"]

Post-treatment monitoring involves repeating antigen testing approximately 6 to 12 months after the final melarsomine injection to confirm clearance [<a href="#ref-12">12</a>, <a href="#ref-24">24</a>]. Cardiac biomarkers such as cTnI may aid in monitoring myocardial injury during treatment [<a href="#ref-19">19</a>]. Radiographic parameters, particularly main pulmonary artery enlargement and loss of vessel margination, can improve after successful therapy [<a href="#ref-21">21</a>].

Prevention

Prevention relies on monthly administration of macrocyclic lactones (ivermectin, milbemycin oxime, moxidectin, selamectin) that kill tissue-stage larvae (L3 and L4) before they reach the pulmonary arteries [<a href="#ref-18">18</a>, <a href="#ref-28">28</a>]. Integrated parasite control using combination products that also target fleas (e.g., moxidectin + imidacloprid) offers additional compliance benefits [<a href="#ref-27">27</a>]. The American Heartworm Society recommends year-round prevention in endemic areas and seasonal prevention in regions with defined transmission windows [<a href="#ref-28">28</a>]. The "Transmission Tracker, Dirofilaria" dashboard provides real-time temperature-based risk assessment to guide such decisions [<a href="#ref-8">8</a>]. Adherence to prevention is the single most important factor; studies have repeatedly shown that lapses in prophylaxis are the predominant cause of infection [<a href="#ref-25">25</a>, <a href="#ref-29">29</a>].

References

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention